免疫应答的种族差异仅部分解释系统性硬化症疾病严重程度的不同
该观察性研究纳入803例黑人和2178例白人系统性硬化症(SSc)患者,系统检测自身抗体并采用logistic回归分析。黑人患者抗Scl70、抗U1RNP、抗U3RNP、抗Th/To、抗Ku和抗NOR90更常见,白人患者ACA、抗POLR3和抗PM/Scl更常见。校正自身抗体后,种族对毛细血管扩张、用力肺活量<70%、肺动脉高压及严重肺、心、肌肉和胃肠道疾病的影响下降11%-44%,而对肾危象和严重肾脏疾病的关联增加37%-52%。
要点
- 黑人SSc患者抗Scl70、抗U1RNP、抗U3RNP、抗Th/To、抗Ku和抗NOR90更常见,白人患者ACA、抗POLR3和抗PM/Scl更常见。
- 黑人患者严重雷诺现象、皮肤、肺、胃肠道和肾脏疾病患病率更高,白人患者严重心脏和肌肉疾病患病率更高。
- 自身抗体仅解释种族对临床结局影响的一小部分,提示其他因素参与结局差异。
核心结论
- 黑人和白人SSc患者具有不同的自身抗体谱。
- 自身抗体仅解释种族对临床结局影响的一小部分,提示其他因素导致两组结局差异。
研究设计与样本
- 观察性研究纳入803例黑人和2178例白人SSc患者,采用Euroimmun系统检测ACA、POLR3、Scl70、PM/Scl、NOR90、Th/To、Ku、U3RNP和Ro52,采用商业ELISA检测U1RNP。
- 采用logistic回归评估自我认定种族与结局的关联并校正自身抗体,通过比较包含与不包含自身抗体的多变量模型中的种族系数来估计自身抗体状态是否介导种族效应。
主要发现
- 黑人队列较白人队列更常见抗Scl70、抗U1RNP、抗U3RNP、抗Th/To、抗Ku和抗NOR90,白人队列富集ACA、抗POLR3和抗PM/Scl。
- 黑人个体严重雷诺现象、皮肤、肺、胃肠道和肾脏疾病患病率更高,白人个体严重心脏和肌肉疾病患病率更高。
- 校正自身抗体后,种族对毛细血管扩张、用力肺活量<70%、肺动脉高压及严重肺、心、肌肉和胃肠道疾病的影响下降11%-44%。
- 校正自身抗体后,种族与肾危象和严重肾脏疾病的关联增加37%-52%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand if autoantibodies account for racial variation in disease severity, we compared autoantibody distribution and associated phenotype between self-identified black and white systemic sclerosis (SSc) patients. METHODS: 803 black and 2178 white SSc patients had systematic testing for autoantibodies using Euroimmun (centromere (ACA), RNA-polymerase III (POLR3), Scl70, PM/Scl, NOR90, Th/To, Ku, U3RNP and Ro52) and commercial ELISA (U1RNP). In this observational study, logistic regression was performed to assess the association between self-identified race and outcomes, adjusting for autoantibodies. To estimate whether the effect of race was mediated by autoantibody status, race coefficients from multivariate models including and excluding autoantibodies were compared. RESULTS: Anti-Scl70, anti-U1RNP, anti-U3RNP, anti-Th/To, anti-Ku and anti-NOR90 were more common in the black cohort than in the white cohort, which was enriched for ACA, anti-POLR3 and anti-PM/Scl. Black individuals had a higher prevalence of severe Raynaud's, skin, lung, gastrointestinal and renal disease whereas white individuals had a higher prevalence of severe heart and muscle disease. Adjusting for autoantibodies decreased the effect of race on outcome for telangiectasias, forced vital capacity <70%, pulmonary hypertension and severe lung, heart, muscle and gastrointestinal disease by 11%-44% and increased the association between race and renal crisis and severe kidney disease by 37%-52%. CONCLUSIONS: This study is the largest systematic analysis of autoantibody responses in a geographically diverse population of black SSc patients. Black and white individuals with SSc have distinct autoantibody profiles. Autoantibodies explain only a fraction of the effect of race on clinical outcomes, suggesting other factors contribute to disparate outcomes between these groups.
引用
- Kuchinad KE, Kim JS, Woods A, et al. Racial variability in immune responses only partially explains differential systemic sclerosis disease severity. Ann Rheum Dis. 2024. PMID: 39019570. doi:10.1136/ard-2023-225458
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。